RAD50 and neoplasm: Control group tumors exhibited sustained growth following cancer cell injection (Fig. 7-a, -b, Additional file 2: Figure S2), between days 1 and 14, IR combined with Ad-RAD50 infection significantly regressed the tumor growth compared with IR alone (P = 0.018).